Skip to main content

Company Name

The “Company Name” field currently displays the company associated with the drug identification number (DIN) as of today. A fix will be implemented shortly so the fields will show the company name as it was when the report was originally posted. This issue does not impact the data that can be extracted from the website using the Application Programming Interface (API).

Reports for EVEROLIMUS

Ingredient

EVEROLIMUS

Shortage reports
Brand name	Strength	Dosage	Status	Date Created	Date Updated	Reports
SANDOZ EVEROLIMUS	2.5MG	TABLET	Resolved	2023-06-28	2023-08-22	196787
SANDOZ EVEROLIMUS	2.5MG	TABLET	Resolved	2022-08-18	2022-09-02	167314
SANDOZ EVEROLIMUS	2.5MG	TABLET	Resolved	2022-05-24	2022-06-04	161192
TEVA-EVEROLIMUS	2.5MG	TABLET	Resolved	2020-04-10	2020-05-14	111807
TEVA-EVEROLIMUS	10MG	TABLET	Actual shortage	2026-02-05	2026-02-05	277393
TEVA-EVEROLIMUS	5MG	TABLET	Resolved	2024-05-09	2025-06-19	227509
TEVA-EVEROLIMUS	5MG	TABLET	Resolved	2020-09-24	2020-10-08	124971
TEVA-EVEROLIMUS	2.5MG	TABLET	Actual shortage	2024-01-11	2024-01-18	215754
TEVA-EVEROLIMUS	2.5MG	TABLET	Resolved	2022-10-28	2022-12-08	173058
TEVA-EVEROLIMUS	2.5MG	TABLET	Resolved	2020-10-01	2021-01-14	125503

Showing 11 to 20 of 21

Discontinuation reports
Brand name	Strength	Dosage	Status	Date Created	Date Updated	Reports
AFINITOR	7.5MG	TABLET	Discontinued	2018-07-09	2018-07-10	54891

1

Showing 1 to 1 of 1